Analyst Ratings for Repligen Corp. (RGEN)

Updated: 2017-07-27

Shares of Repligen Corp. (NASDAQ:RGEN) have received a consensus rating of Overweight from Wall Street analysts. RGEN had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 4 analysts, 0 issued an overweight rating, 2 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

A number of analysts gave price targets for RGEN. The maximum price target given was 50, which equates to a potential upside of 22.79 percent. The minimum price target given was 40, implying potential capital losses of -1.77 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -11.76 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 1.82 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 2 analysts decreased their estimates.

Analysts estimate earnings of RGEN to grow at a rate of 43.7 percent. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of RGEN is 2.45.

RGEN has traded between a high of 46.81 and a low of 26.16 over the past year. Currently the stock is 55.66 percent higher than its low, and 13.01 percent below the high. RGEN has a price/earnings ratio of 107.16. Investors typically compare the P/E ratio to a company's peers in the industry. The RGEN value stock report compares RGEN to some of its peers using value stock charts. The market cap of RGEN is $1.54 billion. RGEN's next earnings release will be on 0000-00-00, which is days away.